ArticleJournal of experimental & clinical cancer research : CR2025
Correction: Targeted Inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.
Bixing Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.